Leland W Chung

Title: Leland W Chung: Innovator in Cancer Treatment

Introduction

Leland W Chung is a notable inventor based in Lovingston, VA (US). He has made significant contributions to the field of cancer treatment, holding a total of 3 patents. His work focuses on innovative methods for the prevention and treatment of cancer, as well as addressing viral and microbial infections.

Latest Patents

Chung's latest patents include groundbreaking methods for the prevention and treatment of cancer using anti-C3b(i) antibodies. This invention relates to the administration of these antibodies to treat and prevent cancer, viral infections, and microbial infections. The methods involve administering IgG antibodies, IgM antibodies, and complement components in combination with antibodies specific for C3b(i). Additionally, his patents cover the detection, imaging, diagnosis, and monitoring of cancer utilizing C3b(i) specific antibodies. Another significant patent involves a therapeutic agent based on a recombinant adenovirus that employs an osteocalcin promoter for the expression of thymidine kinase. This agent can be administered intravascularly to treat various metastatic cancers, providing a preferred route over previous local administration methods.

Career Highlights

Chung is associated with the University of Virginia Patent Foundation, where he continues to advance his research and innovations in cancer treatment. His work has the potential to significantly impact the medical field and improve patient outcomes.

Collaborations

Chung has collaborated with notable colleagues, including Chinghai Kao and Robert A Sikes, to further enhance his research efforts and innovations.

Conclusion

Leland W Chung is a pioneering inventor whose work in cancer treatment and prevention is making strides in the medical community. His innovative approaches and collaborations are paving the way for future advancements in healthcare.